SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-16-000106
Filing Date
2016-03-23
Accepted
2016-03-23 16:03:44
Documents
14
Period of Report
2015-12-31
Effectiveness Date
2016-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A haloproxy2016.htm DEF 14A 1132119
2 a2015eipresults.jpg GRAPHIC 174882
3 a2015peergroup.jpg GRAPHIC 98008
4 ceotargetannualcolor.jpg GRAPHIC 30923
5 compensationelement.jpg GRAPHIC 227113
6 executiveincentivebonuscolor.jpg GRAPHIC 54024
7 finalregcardpage1.jpg GRAPHIC 366675
8 finalregcardpage2.jpg GRAPHIC 281114
9 halologobw.jpg GRAPHIC 38428
10 htsignaturea01.jpg GRAPHIC 31598
11 leonhardtsignature2.jpg GRAPHIC 413112
12 neoshiredin2015color.jpg GRAPHIC 29215
13 psuvestingfinal.jpg GRAPHIC 60760
14 whatwedo.jpg GRAPHIC 192212
  Complete submission text file 0001159036-16-000106.txt   3848384
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 161523944
SIC: 2836 Biological Products, (No Diagnostic Substances)